Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis

被引：13

作者：

Eroglu, A ^{[1
]}

Kurtman, C

Ulu, A

Çam, R

Akar, N

机构：

[1] Numune State Hosp, Dept Gen Surg & Surg Oncol, Konya, Turkey

[2] Ankara Univ, Sch Med, Dept Radiat Oncol, TR-06100 Ankara, Turkey

[3] Ankara Univ, Sch Med, Pediat Mol Genet, TR-06100 Ankara, Turkey

[4] Ankara Univ, Sch Med, Dept Gen Surg, TR-06100 Ankara, Turkey

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 06期

关键词：

D O I：

10.1111/j.1538-7836.2005.01346.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1323 / 1324

页数：2

共 8 条

[1]

Akar N, 1997, THROMB HAEMOSTASIS, V78, P1527

[2]

Eroglu A, 2004, THROMB HAEMOSTASIS, V91, P837

[3] PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer [J].

Eroglu, A ;

Çam, R ;

Yildiz, Z ;

Akar, N .

THROMBOSIS RESEARCH, 2003, 111 (4-5) :317-319

[4] Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism [J].

Haim, N ;

Lanir, N ;

Hoffman, R ;

Haim, A ;

Tsalik, M ;

Brenner, B .

AMERICAN JOURNAL OF MEDICINE, 2001, 110 (02) :91-96

[5] From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer [J].

Levine, MN ;

Lee, AY ;

Kakkar, AK .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1456-1463

[6] Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter [J].

Mandalà, M ;

Curigliano, G ;

Bucciarelli, P ;

Ferretti, G ;

Mannucci, RM ;

Colleoni, M ;

Ventura, A ;

Peruzzotti, G ;

Severi, G ;

Pelicci, PG ;

Biffi, R ;

Orsi, F ;

Cinieril, S ;

Goldhirsch, A .

ANNALS OF ONCOLOGY, 2004, 15 (04) :590-593

[7] Clinical significance of the FV:Q(506) mutation in unselected oncology patients [J].

Otterson, GA ;

Monahan, BP ;

Harold, N ;

Steinberg, SM ;

Frame, JN ;

Kaye, FJ .

AMERICAN JOURNAL OF MEDICINE, 1996, 101 (04) :406-412

[8] Prevalence of factor V Leiden, FII G20210A, FXIII Va134Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis [J].

Ramacciotti, E ;

Wolosker, N ;

Puech-Leao, P ;

Zeratti, EA ;

Gusson, PR ;

del Giglio, A ;

Franco, RF .

THROMBOSIS RESEARCH, 2003, 109 (04) :171-174

← 1 →